Regeneron Pharmaceuticals Share Price (REGN.US)

Regeneron Pharmaceuticals is listed on the CBOE trading with ticker code REGN.US. It has a market capitalisation of $71.94b, with approximately 103.02m shares in issue. Over the last year, Regeneron Pharmaceuticals share price has been traded in a range of 341.02, hitting a high of 817.98, and a low of 476.96.

Regeneron Pharmaceuticals, Inc. is a leading American biotechnology company headquartered in Tarrytown, New York. Founded in 1988, Regeneron specialises in discovering, developing, and commercialising innovative medicines for serious diseases. The company's diverse portfolio includes treatments for conditions such as eye diseases, cancer, cardiovascular diseases, and inflammatory disorders. Notable products include EYLEA, Dupixent, and Libtayo. Committed to scientific excellence and improving patient outcomes, Regeneron invests heavily in research and development. The company's cutting-edge technologies and robust pipeline of potential therapies have established it as a prominent player in the biotechnology industry.